New mums to get £23m mental health funding boost

Amy Schofield 08 February 2018

The NHS has confirmed that extra funding will be made available to improve the mental health of at least 3000 pregnant women and those who have recently given birth.

The £23 million funding is part of a major programme of improvement and investment by NHS England in the mental health of expectant and new mums. A total of 30,000 additional women will get specialist mental health care in person and through online consultations including over Skype during the early stages of motherhood, supported by a total of £365m, by 2021.

Perinatal mental ill health - wellbeing related to pregnancy and the first year of motherhood - affects up to 20% of women. Perinatal services, alongside other treatments for common mental illnesses such as depression and anxiety, can play an important role in ensuring mental health is integrated into overall healthcare at the earliest possible stage of life.

The new funding for community perinatal services follows additional spending since 2016 of £40 million, which will see over 6000 new mums receiving specialist mental health care by April 2018.

The development of community services is part of an overall package of increasing access to perinatal care, which includes four new mother and baby units and the recruitment of over 200 specialist staff, including 21 consultant psychiatrists and more than 100 nurses and therapists.

Claire Murdoch, director of mental health for NHS England, said: “Falling pregnant and becoming a mum is a hugely emotional experience, so having expert support available, including working with people’s partners as well as their wider family and social networks, to help manage the upheaval, means that women who are experiencing mental health issues don’t have to suffer and struggle alone.

“Improving community access to mental health care is the cornerstone of NHS plans to improve services, and the £60 million investment in perinatal mental health will mean women and their families get targeted, specialised support at one of the most important periods of life.”


Make a comment

To voice your opinion, please Log in or Register.

Pf Magazine

Your resource for news, features, interviews, careers and events in the pharma industry.

Click here for the latest issue and to subscribe.